Instantaneous wave-free ratio compared with fractional flow reserve in PCI : A cost-minimization analysis
(2021) In International Journal of Cardiology 344. p.54-59- Abstract
Background: Coronary physiology is a routine diagnostic tool when assessing whether coronary revascularization is indicated. The iFR-SWEDEHEART trial demonstrated similar clinical outcomes when using instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) to guide revascularization. The objective of this analysis was to assess a cost-minimization analysis of iFR-guided compared with FFR-guided revascularization. Methods: In this cost-minimization analysis we used a decision-tree model from a healthcare perspective with a time-horizon of one year to estimate the cost difference between iFR and FFR in a Nordic setting and a United States (US) setting. Treatment pathways and health care utilizations were constructed from the... (More)
Background: Coronary physiology is a routine diagnostic tool when assessing whether coronary revascularization is indicated. The iFR-SWEDEHEART trial demonstrated similar clinical outcomes when using instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) to guide revascularization. The objective of this analysis was to assess a cost-minimization analysis of iFR-guided compared with FFR-guided revascularization. Methods: In this cost-minimization analysis we used a decision-tree model from a healthcare perspective with a time-horizon of one year to estimate the cost difference between iFR and FFR in a Nordic setting and a United States (US) setting. Treatment pathways and health care utilizations were constructed from the iFR-SWEDEHEART trial. Unit cost for revascularization and myocardial infarction in the Nordic setting and US setting were derived from the Nordic diagnosis-related group versus Medicare cost data. Unit cost of intravenous adenosine administration and cost per stent placed were based on the average costs from the enrolled centers in the iFR-SWEDEHEART trial. Deterministic and probabilistic sensitivity analyses were carried out to test the robustness of the result. Results: The cost-minimization analysis demonstrated a cost saving per patient of $681 (95% CI: $641 - $723) in the Nordic setting and $1024 (95% CI: $934 - $1114) in the US setting, when using iFR-guided compared with FFR-guided revascularization. The results were not sensitive to changes in uncertain parameters or assumptions. Conclusions: IFR-guided revascularization is associated with significant savings in cost compared with FFR-guided revascularization.
(Less)
- author
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Cost-minimization analysis, Fractional flow reserve, Instantaneous wave-free ratio
- in
- International Journal of Cardiology
- volume
- 344
- pages
- 54 - 59
- publisher
- Elsevier
- external identifiers
-
- pmid:34600977
- scopus:85116405847
- ISSN
- 0167-5273
- DOI
- 10.1016/j.ijcard.2021.09.054
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2021 The Author(s)
- id
- 631070a7-08f9-413e-acec-375226b97981
- date added to LUP
- 2021-10-25 14:48:21
- date last changed
- 2025-04-04 14:13:32
@article{631070a7-08f9-413e-acec-375226b97981, abstract = {{<p>Background: Coronary physiology is a routine diagnostic tool when assessing whether coronary revascularization is indicated. The iFR-SWEDEHEART trial demonstrated similar clinical outcomes when using instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) to guide revascularization. The objective of this analysis was to assess a cost-minimization analysis of iFR-guided compared with FFR-guided revascularization. Methods: In this cost-minimization analysis we used a decision-tree model from a healthcare perspective with a time-horizon of one year to estimate the cost difference between iFR and FFR in a Nordic setting and a United States (US) setting. Treatment pathways and health care utilizations were constructed from the iFR-SWEDEHEART trial. Unit cost for revascularization and myocardial infarction in the Nordic setting and US setting were derived from the Nordic diagnosis-related group versus Medicare cost data. Unit cost of intravenous adenosine administration and cost per stent placed were based on the average costs from the enrolled centers in the iFR-SWEDEHEART trial. Deterministic and probabilistic sensitivity analyses were carried out to test the robustness of the result. Results: The cost-minimization analysis demonstrated a cost saving per patient of $681 (95% CI: $641 - $723) in the Nordic setting and $1024 (95% CI: $934 - $1114) in the US setting, when using iFR-guided compared with FFR-guided revascularization. The results were not sensitive to changes in uncertain parameters or assumptions. Conclusions: IFR-guided revascularization is associated with significant savings in cost compared with FFR-guided revascularization.</p>}}, author = {{Berntorp, Karolina and Persson, Josefine and Koul, Sasha M. and Patel, Manesh R. and Christiansen, Evald H. and Gudmundsdottir, Ingibjörg and Yndigegn, Troels and Omerovic, Elmir and Erlinge, David and Fröbert, Ole and Götberg, Matthias}}, issn = {{0167-5273}}, keywords = {{Cost-minimization analysis; Fractional flow reserve; Instantaneous wave-free ratio}}, language = {{eng}}, pages = {{54--59}}, publisher = {{Elsevier}}, series = {{International Journal of Cardiology}}, title = {{Instantaneous wave-free ratio compared with fractional flow reserve in PCI : A cost-minimization analysis}}, url = {{http://dx.doi.org/10.1016/j.ijcard.2021.09.054}}, doi = {{10.1016/j.ijcard.2021.09.054}}, volume = {{344}}, year = {{2021}}, }